HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The efficacy of verapamil in sustained monomorphic ventricular tachycardia].

Abstract
We present a 36-year-old male without overt cardiac disease who suffered, since he was 15 years old, from sustained monomorphic ventricular tachycardia of left bundle branch block with a right axis, lasting for several hours; sometimes, syncope was a clinical form of manifestation. Electrophysiologic study, twenty-four hours Holter recording, cardiac catheterization and blood analysis were not useful in order to find its etiology. Efficacy of different drugs, like Mexiletil, Amiodarone, Atenolol and Verapamil (at a dose of 240 mg/day) were tested through multistaged graded-treadmill stress-testing using the Bruce protocol. Ventricular tachycardia was suppressed by administration of Lidocaine. Oral verapamil given at a dose of 360 mg/day prevented the induction of the arrhythmia, the efficacy was tested with maximal treadmill exercise and twenty-four hours Holter recording.
AuthorsJ R Rumoroso, A Bodegas, J Subinas, P M Montes, R Sanz, D Rodrigo, J I Barrenetxea
JournalRevista espanola de cardiologia (Rev Esp Cardiol) Vol. 47 Issue 9 Pg. 633-5 (Sep 1994) ISSN: 0300-8932 [Print] Spain
Vernacular TitleEficacia del verapamilo en la taquicardia ventricular monomorfa sostenida.
PMID7973032 (Publication Type: Case Reports, English Abstract, Journal Article, Review)
Chemical References
  • Verapamil
Topics
  • Adult
  • Cardiac Pacing, Artificial
  • Chronic Disease
  • Drug Evaluation
  • Electrocardiography, Ambulatory (drug effects)
  • Exercise Test (drug effects)
  • Humans
  • Male
  • Tachycardia, Ventricular (diagnosis, drug therapy)
  • Verapamil (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: